SLX-100
Oncology (specific indication undisclosed)
Phase 2Active
Key Facts
Indication
Oncology (specific indication undisclosed)
Phase
Phase 2
Status
Active
Company
About Lotus Pharmaceuticals
Taiwan‑based specialty pharma delivering oncology‑focused generics, biosimilars and NCEs across 90+ markets.
View full company profile